Impax Laboratories Revenue, Growth & Competitor Profile

DBA IMPAX PHARMACEUTICALS

Company Profile & Annual Report for Impax Laboratories

Access the complete profile.

Impax Laboratories Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	30831 Huntwood Ave Hayward, CA 94544

Impax Laboratories's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Impax Laboratories's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Impax Laboratories is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Impax Laboratories is a publicly traded company on using the ticker symbol IPXL. Detailed information on company financials and operating reports can be found here: : IPXL

Impax Laboratories Annual Revenue and Growth Rate

Impax Laboratories	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	Over $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Impax Laboratories's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Impax Laboratories is developing and marketing. Impax Laboratories doesn't have any recent trademark applications, indicating Impax Laboratories is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
NUMIENT Pharmaceutical preparations for the treatment of neurological disorders and diseases	04/15/2015
MYRYTARY Computer application software for mobile devices, namely, software for patients to access information related to and maintain compliance with treatments for neurological disorders	01/22/2015
LINEAGE THERAPEUTICS pharmaceutical preparations, namely, anthelmintics, antibacterials, antidepressants, anti-infectives, anti-malarial agents, hematologic and oncologic agents; pharmaceutical preparations for the treatment of anaphylaxis, metabolic disorders, inflammatory disorders, autoimmune disorders, diseases of the central nervous system, diseases of the cardiovascular system, and diseases of the respiratory system	03/29/2013

See all trademarks and details in the Full Report.

Market Share of Impax Laboratories's Largest Competitors

A competitive analysis shows these companies are in the same general field as Impax Laboratories, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Impax Laboratories. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
IMPAX LABORATORIES	Hayward, CA	100
SIGHTGLASS MGMT	Alameda, CA	84
ASTEX PHARMACEUTICALS	Pleasanton, CA	25
INTUITY MEDICAL	Fremont, CA	25
ALEXZA PHARMACEUTICALS	Fremont, CA	19
VECTOR LABORATORIES	Newark, CA	15

Future Competition: Impax Laboratories's Fastest Growing Competitors

These companies are in the same general field as Impax Laboratories and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)